Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Neogen Corporation - SIC # 3850 -
Ticker
Exchange
SIC #
Website
Latest Ticker
NEOG
Nasdaq
3850
www.neogen.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Neogen Corporation
Neogen Corporation (NEOG): A Bull Case Theory
- Dec 4th, 2025 10:46 am
3 Unprofitable Stocks with Questionable Fundamentals
- Dec 3rd, 2025 9:37 pm
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds
- Dec 1st, 2025 4:03 am
How Recent Developments Are Shaping the Neogen Chemicals Investment Story
- Nov 27th, 2025 5:17 pm
Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To Know
- Nov 24th, 2025 5:00 pm
CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know
- Nov 21st, 2025 4:36 pm
Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know
- Nov 11th, 2025 1:55 pm
Does Neogen's (NEOG) CFO Transition Signal a New Phase for Its Financial Strategy?
- Nov 8th, 2025 7:15 pm
Assessing Neogen (NEOG) Valuation Following Recent Earnings and Turnaround Signs
- Nov 8th, 2025 6:11 pm
3 of Wall Street’s Favorite Stocks Walking a Fine Line
- Nov 6th, 2025 9:35 pm
Neogen (NASDAQ:NEOG) Q3 Earnings: Leading The Medical Devices & Supplies - Diversified Pack
- Nov 4th, 2025 8:34 pm
Neogen Corp (NEOG) Q1 2026 Earnings Call Highlights: Strategic Cost Reductions and Innovation ...
- Nov 4th, 2025 6:01 pm
Wall Street Analysts See a 29.89% Upside in Neogen (NEOG): Can the Stock Really Move This High?
- Nov 4th, 2025 7:55 am
Neogen® Corporation Announces Appointment of Bryan Riggsbee as Chief Financial Officer
- Oct 30th, 2025 6:45 am
Neogen (NEOG): Assessing Valuation Following Net Income Growth and Recent Share Price Rebound
- Oct 19th, 2025 7:13 am
3 Russell 2000 Stocks We Find Risky
- Oct 16th, 2025 10:35 pm
5 Revealing Analyst Questions From Neogen’s Q3 Earnings Call
- Oct 15th, 2025 11:31 pm
2 Unprofitable Stocks for Long-Term Investors and 1 We Question
- Oct 14th, 2025 10:31 pm
Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know
- Oct 10th, 2025 1:51 pm
Neogen (NEOG): Losses Deepen 90.4% Annually, Market Discounts Turnaround Narrative
- Oct 10th, 2025 9:10 am
Scroll